Ozempic is the brand name for
semaglutide, a once-weekly injectable that belongs to a class of medications called GLP-1 receptor agonists. It's FDA-approved specifically to help manage blood sugar in adults with type 2 diabetes and to reduce cardiovascular risk in that population.
Ozempic is
not FDA-approved as a weight-loss treatment. That approval belongs to
Wegovy, which contains the same active ingredient at different dosing. That said, providers can legally prescribe Ozempic off-label for weight management when they judge it clinically appropriate for a specific patient — a decision a Zealthy provider will walk you through if you're exploring your options.